Protide Pharmaceuticals Inc (PPMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 08-2003 | 08-2002 | 08-2001 | 08-2000 | 08-1999 | |
| Sales | 500 | 400 | 200 | 200 | 0 |
| Cost of Goods | 140 | 160 | 90 | 90 | N/A |
| Gross Profit | 360 | 240 | 100 | 100 | 110 |
| Operating Expenses | 590 | 610 | 600 | 520 | 160 |
| Operating Income | -90 | -210 | -400 | -320 | -160 |
| Interest Expense | 3 | 3 | 4 | 0 | 0 |
| Other Income | 3 | 13 | 44 | 20 | 0 |
| Pre-tax Income | -90 | -200 | -360 | -300 | -160 |
| Net Income Continuous | -90 | -200 | -360 | -300 | -160 |
| Net Income | $-90 | $-200 | $-360 | $-300 | $-160 |
| EPS Basic Total Ops | -0.02 | -0.05 | -0.10 | -0.11 | -0.13 |
| EPS Basic Continuous Ops | -0.02 | -0.05 | -0.10 | -0.11 | -0.13 |
| EBITDA(a) | $-60 | $-180 | $-370 | $-290 | $-110 |